BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29361987)

  • 21. The cell polarity determinant CDC42 controls division symmetry to block leukemia cell differentiation.
    Mizukawa B; O'Brien E; Moreira DC; Wunderlich M; Hochstetler CL; Duan X; Liu W; Orr E; Grimes HL; Mulloy JC; Zheng Y
    Blood; 2017 Sep; 130(11):1336-1346. PubMed ID: 28778865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells.
    Steidl U; Rosenbauer F; Verhaak RG; Gu X; Ebralidze A; Otu HH; Klippel S; Steidl C; Bruns I; Costa DB; Wagner K; Aivado M; Kobbe G; Valk PJ; Passegué E; Libermann TA; Delwel R; Tenen DG
    Nat Genet; 2006 Nov; 38(11):1269-77. PubMed ID: 17041602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells.
    Zhang X; Su J; Jeong M; Ko M; Huang Y; Park HJ; Guzman A; Lei Y; Huang YH; Rao A; Li W; Goodell MA
    Nat Genet; 2016 Sep; 48(9):1014-23. PubMed ID: 27428748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Setd2 deficiency impairs hematopoietic stem cell self-renewal and causes malignant transformation.
    Zhang YL; Sun JW; Xie YY; Zhou Y; Liu P; Song JC; Xu CH; Wang L; Liu D; Xu AN; Chen Z; Chen SJ; Sun XJ; Huang QH
    Cell Res; 2018 Apr; 28(4):476-490. PubMed ID: 29531312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms].
    Müller-Tidow C; Steur C; Mizuki M; Schwäble J; Brandts C; Berdel WE; Serve H
    Dtsch Med Wochenschr; 2002 Oct; 127(42):2195-200. PubMed ID: 12397548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Different Cytokine Conditions Reveals Resveratrol as a New Molecule for Ex Vivo Cultivation of Cord Blood-Derived Hematopoietic Stem Cells.
    Heinz N; Ehrnström B; Schambach A; Schwarzer A; Modlich U; Schiedlmeier B
    Stem Cells Transl Med; 2015 Sep; 4(9):1064-72. PubMed ID: 26160960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular mechanisms in the development of acute myeloid leukemia].
    Ichikawa M; Kurokawa M
    Nihon Rinsho; 2009 Oct; 67(10):1889-93. PubMed ID: 19860185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Independent origins of fetal liver haematopoietic stem and progenitor cells.
    Yokomizo T; Ideue T; Morino-Koga S; Tham CY; Sato T; Takeda N; Kubota Y; Kurokawa M; Komatsu N; Ogawa M; Araki K; Osato M; Suda T
    Nature; 2022 Sep; 609(7928):779-784. PubMed ID: 36104564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukemogenic potency of the novel FLT3-N676K mutant.
    Huang K; Yang M; Pan Z; Heidel FH; Scherr M; Eder M; Fischer T; Büsche G; Welte K; von Neuhoff N; Ganser A; Li Z
    Ann Hematol; 2016 Apr; 95(5):783-91. PubMed ID: 26891877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plzf drives MLL-fusion-mediated leukemogenesis specifically in long-term hematopoietic stem cells.
    Ono R; Masuya M; Nakajima H; Enomoto Y; Miyata E; Nakamura A; Ishii S; Suzuki K; Shibata-Minoshima F; Katayama N; Kitamura T; Nosaka T
    Blood; 2013 Aug; 122(7):1271-83. PubMed ID: 23838347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging hematopoietic precursor division in real time.
    Wu M; Kwon HY; Rattis F; Blum J; Zhao C; Ashkenazi R; Jackson TL; Gaiano N; Oliver T; Reya T
    Cell Stem Cell; 2007 Nov; 1(5):541-54. PubMed ID: 18345353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncogenic N-Ras and Tet2 haploinsufficiency collaborate to dysregulate hematopoietic stem and progenitor cells.
    Jin X; Qin T; Zhao M; Bailey N; Liu L; Yang K; Ng V; Higashimoto T; Coolon R; Ney G; Figueroa ME; Li Q
    Blood Adv; 2018 Jun; 2(11):1259-1271. PubMed ID: 29866713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models.
    Ono R; Masuya M; Inoue N; Shinmei M; Ishii S; Maegawa Y; Maharjan BD; Katayama N; Nosaka T
    PLoS One; 2021; 16(3):e0248425. PubMed ID: 33705482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression.
    Cimmino L; Dolgalev I; Wang Y; Yoshimi A; Martin GH; Wang J; Ng V; Xia B; Witkowski MT; Mitchell-Flack M; Grillo I; Bakogianni S; Ndiaye-Lobry D; Martín MT; Guillamot M; Banh RS; Xu M; Figueroa ME; Dickins RA; Abdel-Wahab O; Park CY; Tsirigos A; Neel BG; Aifantis I
    Cell; 2017 Sep; 170(6):1079-1095.e20. PubMed ID: 28823558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dnmt3a deletion cooperates with the Flt3/ITD mutation to drive leukemogenesis in a murine model.
    Poitras JL; Heiser D; Li L; Nguyen B; Nagai K; Duffield AS; Gamper C; Small D
    Oncotarget; 2016 Oct; 7(43):69124-69135. PubMed ID: 27636998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
    Al-Mawali A; Gillis D; Lewis I
    J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic stem cells are intrinsically protected against MLL-ENL-mediated transformation.
    Ugale A; Norddahl GL; Wahlestedt M; Säwén P; Jaako P; Pronk CJ; Soneji S; Cammenga J; Bryder D
    Cell Rep; 2014 Nov; 9(4):1246-55. PubMed ID: 25456127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The shortest isoform of C/EBPβ, liver inhibitory protein (LIP), collaborates with Evi1 to induce AML in a mouse BMT model.
    Watanabe-Okochi N; Yoshimi A; Sato T; Ikeda T; Kumano K; Taoka K; Satoh Y; Shinohara A; Tsuruta T; Masuda A; Yokota H; Yatomi Y; Takahashi K; Kitaura J; Kitamura T; Kurokawa M
    Blood; 2013 May; 121(20):4142-55. PubMed ID: 23547050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.
    Moran-Crusio K; Reavie L; Shih A; Abdel-Wahab O; Ndiaye-Lobry D; Lobry C; Figueroa ME; Vasanthakumar A; Patel J; Zhao X; Perna F; Pandey S; Madzo J; Song C; Dai Q; He C; Ibrahim S; Beran M; Zavadil J; Nimer SD; Melnick A; Godley LA; Aifantis I; Levine RL
    Cancer Cell; 2011 Jul; 20(1):11-24. PubMed ID: 21723200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.